These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4197709)

  • 21. Synthesis and antitumor activity of 2-deamino- and N2-(gamma-hydroxypropyl)actinomycin D.
    Moore S; Kondo M; Copeland M; Meienhofer J
    J Med Chem; 1975 Nov; 18(11):1098-101. PubMed ID: 809581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N7-Substituted 7-aminoactinomycin D analogues. Synthesis and biological properties.
    Madhavarao MS; Chaykovsky M; Sengupta SK
    J Med Chem; 1978 Sep; 21(9):958-61. PubMed ID: 722760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of bis-dipeptide and bis-tripeptide analogues of actinomycin D.
    Azad Chowdhury AK; Brown JR; Longmore RB
    J Med Chem; 1978 Jul; 21(7):607-12. PubMed ID: 97381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors. IV. Actinomycin-D.
    Twentyman PR; Kallman RF; Brown JM
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1601-3. PubMed ID: 536268
    [No Abstract]   [Full Text] [Related]  

  • 25. Self-immolative prodrugs: candidates for antibody-directed enzyme prodrug therapy in conjunction with a nitroreductase enzyme.
    Mauger AB; Burke PJ; Somani HH; Friedlos F; Knox RJ
    J Med Chem; 1994 Oct; 37(21):3452-8. PubMed ID: 7932574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of actinomycin D-induced resistance in Ridgway osteogenic sarcoma: an ultrastructural study.
    Kamel HM; Merry S; Toner PG
    J Submicrosc Cytol Pathol; 1988 Jan; 20(1):225-35. PubMed ID: 3163515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Shc/Grb2 protein-protein interaction suppresses growth of B104-1-1 tumors xenografted in nude mice.
    Kim HK; Jeong MJ; Kong MY; Han MY; Son KH; Kim HM; Hong SH; Kwon BM
    Life Sci; 2005 Dec; 78(3):321-8. PubMed ID: 16146636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Actinomycin and antitumor antibiotics.
    Young CW
    Am J Clin Pathol; 1969 Aug; 52(2):130-7. PubMed ID: 5798361
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of variamycin on RNA biosynthesis in isolated cell nuclei of rat M-1 sarcoma and liver].
    Rubtsova GV; Eselevich MM; Votrin II; Debov SS; Sazykin IuO
    Biokhimiia; 1972; 37(3):531-6. PubMed ID: 4261537
    [No Abstract]   [Full Text] [Related]  

  • 30. [Synthesis of actinomycin analogues. IV. Synthesis of 2-amino-4, 6-dimethylphe-noxazone-(3)-1, 9-bis-peptides].
    Li SW; Zheng YP; Gao YS
    Yao Xue Xue Bao; 1982 May; 17(5):338-43. PubMed ID: 6184943
    [No Abstract]   [Full Text] [Related]  

  • 31. Combination therapy with radiation and mithromycin or actinomycin D in a transplanted mouse glioma.
    McNulty TB; Dirks VA; Yarbro JW; Kennedy BJ
    Cancer; 1969 Jun; 23(6):1273-9. PubMed ID: 5771063
    [No Abstract]   [Full Text] [Related]  

  • 32. Actinomycin D in the treatment of metastatic osteogenic sarcoma.
    Caceres E; Moran ME
    Cancer Treat Rep; 1977; 61(3):498-9. PubMed ID: 266973
    [No Abstract]   [Full Text] [Related]  

  • 33. Concepts for controlling drug-resistant tumor cells.
    Schabel FM; Skipper HE; Trader MW; Laster WR; Corbett TH; Griswold DP
    Eur J Cancer (1965); 1980; Suppl 1():199-211. PubMed ID: 6947891
    [No Abstract]   [Full Text] [Related]  

  • 34. Actinomycin D absorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor.
    Brasseur F; Couvreur P; Kante B; Deckers-Passau L; Roland M; Deckers C; Speiser P
    Eur J Cancer (1965); 1980 Nov; 16(11):1441-5. PubMed ID: 7227421
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis and biological properties of N2-substituted spin-labeled analogues of actinomycin D.
    Sinha BK; Cox MG; Chignell CF; Cysyk RL
    J Med Chem; 1979 Sep; 22(9):1051-5. PubMed ID: 226705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross resistance between actinomycin-D, adriamycin and vincristine in a murine solid tumour in vivo.
    Kaye SB; Boden JA
    Biochem Pharmacol; 1980 Apr; 29(7):1081-4. PubMed ID: 7387723
    [No Abstract]   [Full Text] [Related]  

  • 37. Enantiomers of 7-(2,3-epoxypropoxy)actinomycin D as dual-action DNA-acting antitumor agents.
    Sengupta SK; Rosenbaum DP; Sehgal RK; Almassian B; Blondin J
    J Med Chem; 1988 Aug; 31(8):1540-7. PubMed ID: 3397991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of primary macroglobulinemia responded to actinomycin D and aclacinomycin A].
    Toyokawa Y; Yoshida Y; Uchiyama T; Kanoh T; Uchino H; Ito K; Kasakura S; Sotobayashi H; Osamura Y; Mizuno Y
    Rinsho Ketsueki; 1984 Aug; 25(8):1239-43. PubMed ID: 6439914
    [No Abstract]   [Full Text] [Related]  

  • 39. [Kinetin, nucleic acids and vitamin B6 as antagonists of Neurospora and Lactobacillus casei].
    Wagner-Jauregg T; Fischer J
    Arzneimittelforschung; 1974 Mar; 24(3):278-85. PubMed ID: 4276219
    [No Abstract]   [Full Text] [Related]  

  • 40. [Origin and bases of cancer chemotherapy (author's transl)].
    Umezawa H
    Tanpakushitsu Kakusan Koso; 1978 May; 23(6):657-76. PubMed ID: 80810
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.